Clinical Study
Topical 100% Serum Eye Drops for Treating Corneal Epithelial Defect after Ocular Surgery
Table 3
Summary of 11 patients unresponsive to serum eye drops treatment.
| Diagnosis | Indication | Number (%) | Increased dosage | Further treatment |
| Alkali injuries | Tectonic PK | 1 (0.55) | 100% ASE q 1 hr | AMT with tarsorrhaphy | Ocular cicatricial pemphigoid | Therapeutic PK | 1 (0.55) | 100% AlloSE q 1 hr | AMT with tarsorrhaphy | Severe fungal keratitis | Therapeutic PK | 2 (1.10) | 100% ASE q 1 hr | AMT (2), Gunderson conjunctival flap (1) | Stevens-Johnson syndrome | | | | | (i) Corneal ulcer failed medical therapy | Therapeutic PK | 2 (1.10) | 100% ASE q 1 hr | AMT with tarsorrhaphy (2) | (ii) Corneal melting and perforation | Therapeutic PK | 2 (1.10) | 100% ASE q 1 hr | AMT with tarsorrhaphy (1), evisceration (1) | (iii) Post-Boston keratoprosthesis surgery | Optical | 3 (1.66)
| 100% ASE q 1 hr | Regraft, glue adhesion, and tarsorrhaphy (2), evisceration (1) |
|
|
ASE: autologous serum eye drops; AlloSE: allogeneic serum eye drops; PK: penetrating keratoplasty; AMT: amniotic membrane transplantation.
|